Dr. Peccoud is a synthetic biology pioneer who quickly understood the potential of a model-driven approach to the development of biotechnology products.Dr. Peccoud founded GenoFAB to support the synthetic biology programs of biotech companies and research organizations who need to accelerate the development of revolutionary products used to save lives, feed the world, and support sustainable economic growth.Today, Dr. Peccoud is the Abell Chair in Synthetic Biology in the Department of Chemical and Biological Engineering at Colorado State University (CSU). He leads the Colorado Cyberbiofoundry, a high-throughput facility to accelerate the development of new viral vectors and other gene delivery systems for biomedical applications.He is the founding Editor-in-Chief of the journal Synthetic Biology, published by Oxford University Press. Dr. Peccoud is on the editorial boards for Trends in Biotechnology and Nucleic Acids Research and has published more than 100 articles with more than 4,000 citations.Since 2008, Dr. Peccoud has advised the U.S. Department of Defense, Department of Justice, and members of the intelligence community to help them anticipate and manage cyberbiosecurity threats emerging at the interface between biological space and cyberspace. He is a member of the Engineering Biology Research Consortium Council and Security Working Group. Looking forward, Dr. Peccoud is creating an indelible imprint with GenoFAB by proposing a new R&D paradigm at the intersection of science and engineering.
Listed skills include Bioinformatics, Biotechnology, Genetics, Molecular Biology, and 38 others.